Jul. 17 at 6:52 PM
$ENHA +20.08% today, finally giving bulls something to celebrate.
The past few weeks tested patience, but that’s the reality with high-risk, high-reward small caps. These names rarely move smoothly, and investors need to be ready for volatility in both directions.
Today’s move is encouraging, but the bigger event I’m watching is next week’s FDA Pharmacy Compounding Advisory Committee meeting.
The committee will review seven peptides over two days, including BPC-157, TB-500, MOTS-C, KPV, Semax, Epitalon, and DSIP.
The recommendations are non-binding, but the meeting could become an important catalyst for
$ENHA and bring more attention to the peptide space.